Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-15-000110
Filing Date
2015-02-13
Accepted
2015-02-13 12:01:54
Documents
3
Group Members
ASCENT BIOMEDICAL VENTURES I ANNEX, L.P.ASCENT BIOMEDICAL VENTURES I NY, L.P.ASCENT BIOMEDICAL VENTURES I, L.P.GEOFFREY W. SMITHSTEVE HOCHBERG

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ss416431_sc13ga.htm SC 13G/A 194389
2 JOINT FILING AGREEMENT ss416431_ex99a.htm EX-99.A 21216
3 ITEM 8 STATEMENT ss416431_ex99b.htm EX-99.B 11136
  Complete submission text file 0000947871-15-000110.txt   228513
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87880 | Film No.: 15611406
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 W. 57TH STREET SUITE 4A NEW YORK NY 10019
Business Address 142 W. 57TH STREET SUITE 4A NEW YORK NY 10019 212-688-8897
ABV, LLC (Filed by) CIK: 0001599498 (see all company filings)

EIN.: 061733944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A